Defence And Security Tenders

Conclusion of Non-Exclusive Discount Agreements According to § 130 a Paragraph 8 Sgb V for Drugs with the Active Ingredient Permethrin

Dns for Av Technology 2017 to 2019

Conclusion of Non-Exclusive Discount Agreements According to § 130 a Paragraph 8 Sgb V for Drugs with the Active Ingredient Palonosetron Wka

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Isosorbide Dinitrate, Atc Code: C01da08 for the Period from 06/01/2023 to 05/31/2025

Supplementary Tendering for Outpatient Services for Specialized Ophthalmic Care: Ophthalmologist's Reception and Examination Visits

Das Strategic Administrative Advice

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Medicines Containing the Active Ingredient Mepolizumab (Atc: R03dx09)

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Vinorelbine, Atc Code: L01ca04 for the Period from 06/01/2023 to 05/31/2025

Drugs with the Active Ingredient Ibuprofen (Atc: M01ae01 - in Sustained-Release Dosage Form with a Potency of 800 Mg)